全文获取类型
收费全文 | 47672篇 |
免费 | 5031篇 |
国内免费 | 114篇 |
专业分类
耳鼻咽喉 | 444篇 |
儿科学 | 1285篇 |
妇产科学 | 1201篇 |
基础医学 | 7101篇 |
口腔科学 | 1073篇 |
临床医学 | 5974篇 |
内科学 | 8760篇 |
皮肤病学 | 569篇 |
神经病学 | 4629篇 |
特种医学 | 1799篇 |
外国民族医学 | 57篇 |
外科学 | 6127篇 |
综合类 | 1018篇 |
一般理论 | 47篇 |
预防医学 | 5336篇 |
眼科学 | 1135篇 |
药学 | 3538篇 |
中国医学 | 24篇 |
肿瘤学 | 2700篇 |
出版年
2021年 | 694篇 |
2020年 | 445篇 |
2019年 | 706篇 |
2018年 | 783篇 |
2017年 | 600篇 |
2016年 | 654篇 |
2015年 | 690篇 |
2014年 | 1040篇 |
2013年 | 1599篇 |
2012年 | 2199篇 |
2011年 | 2254篇 |
2010年 | 1321篇 |
2009年 | 1127篇 |
2008年 | 2075篇 |
2007年 | 2084篇 |
2006年 | 2099篇 |
2005年 | 2027篇 |
2004年 | 2046篇 |
2003年 | 1818篇 |
2002年 | 1773篇 |
2001年 | 1492篇 |
2000年 | 1614篇 |
1999年 | 1381篇 |
1998年 | 600篇 |
1997年 | 519篇 |
1996年 | 477篇 |
1995年 | 484篇 |
1994年 | 440篇 |
1993年 | 404篇 |
1992年 | 1071篇 |
1991年 | 1114篇 |
1990年 | 1025篇 |
1989年 | 1004篇 |
1988年 | 1009篇 |
1987年 | 879篇 |
1986年 | 866篇 |
1985年 | 844篇 |
1984年 | 700篇 |
1983年 | 582篇 |
1982年 | 389篇 |
1981年 | 359篇 |
1980年 | 346篇 |
1979年 | 663篇 |
1978年 | 517篇 |
1977年 | 437篇 |
1976年 | 417篇 |
1975年 | 382篇 |
1974年 | 439篇 |
1973年 | 437篇 |
1972年 | 378篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
992.
993.
994.
995.
996.
Using action research to develop midwives’ skills to support women with perinatal mental health needs
下载免费PDF全文
![点击此处可从《Journal of clinical nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
997.
Esmerina Tili Marcela Chiabai Dario Palmieri Melissa Brown Ri Cui Cecilia Fernandes Tim Richmond Taewan Kim Tyler Sheetz Hui-Lung Sun Alessandro Lagana Dario Veneziano Stefano Volinia Laura Rassenti Thomas Kipps Hamdy Awad Jean-Jacques Michaille Carlo M. Croce 《Oncotarget》2015,6(28):24599-24610
Quaking (QKI) is a tumor-suppressor gene encoding a conserved RNA-binding protein, whose expression is downregulated in several solid tumors. Here we report that QKI plays an important role in the immune response and suppression of leukemogenesis. We show that the expression of Qki is reduced in lipopolysaccharide (LPS)-challenged macrophages, suggesting that Qki is a key regulator of LPS signaling pathway. Furthermore, LPS-induced downregulation of Qki expression is miR-155-dependent. Qki overexpression impairs LPS-induced phosphorylation of JNK and particularly p38 MAPKs, in addition to increasing the production of anti-inflammatory cytokine IL-10. In contrast, Qki ablation decreases Fas expression and the rate of Caspase3/7 activity, while increasing the levels of IL-1α, IL-1β and IL-6, and p38 phosphorylation. Similarly, the p38 pathway is also a target of QKI activity in chronic lymphocytic leukemia (CLL)-derived MEC2 cells. Finally, B-CLL patients show lower levels of QKI expression compared with B cells from healthy donor, and Qki is similarily downregulated with the progression of leukemia in Eμ-miR-155 transgenic mice. Altogether, these data implicate QKI in the pathophysiology of inflammation and oncogenesis where miR-155 is involved. 相似文献
998.
E. Provenzano J.P. Brown S.E. Pinder 《Clinical oncology (Royal College of Radiologists (Great Britain))》2013,25(2):80-92
The pathological classification of breast cancer is constantly being updated to reflect the advances in our clinical and biological understanding of the disease. This overview examines new insights into the classification and molecular biology of ductal carcinoma in situ, the pathological handling of sentinel lymph node biopsies and the identification of low volume disease (micrometastases and isolated tumour cells) and the handling and reporting of specimens after neoadjuvant therapy. The molecular subtypes of invasive breast cancer are also represented in ductal carcinoma in situ. It is hoped that alongside traditional histological features, such as cytological grade and the presence of necrosis, this will lead to better classification systems with improved prediction of clinical behaviour, in particular the risk of progression to invasive cancer, and enable more targeted management. Sentinel lymph node biopsy is now the standard of care for early stage breast cancer in clinically node-negative patients. However, the handling and reporting of these specimens remains controversial, largely related to the uncertainties regarding the clinical significance of micrometastases and isolated tumour cells. The increasing use of neoadjuvant therapies has introduced challenges for the pathologist in the handling and interpretation of these specimens. Grading the tumour response, particularly the identification of a complete pathological response, is prognostically important. However, there is still marked variability in reporting these specimens in routine practice, and consensus guidelines for the histopathology reporting of breast cancers after neoadjuvant chemotherapy based on robust, validated evidence are presently lacking. 相似文献
999.
Paula Brown 《Journal of cancer education》2012,27(4):251-333
1000.